TITLE

Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma

AUTHOR(S)
Sezer, O.; Niemöller, K.; Eucker, J.; Jakob, C.; Kaufmann, O.; Zavrski, I.; Dietel, M.; Possinger, K.
PUB. DATE
October 2000
SOURCE
Annals of Hematology;Oct2000, Vol. 79 Issue 10, p574
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The importance of neoangiogenesis for the progressive growth and viability of solid tumors is well established. Recently, there has been growing evidence that angiogenesis might also be important in hematological malignancies, but only few data are available. In this report, we have studied the impact of bone marrow microvessel density and survival in patients with multiple myeloma (MM). Immunohistochemical CD34 stained paraffin-embedded bone marrow biopsies of 44 patients with newly diagnosed MM were studied. Microvessels were counted in 400× magnification and the mean number of vessels per area in each sample was noted as the microvessel density (MVD). The median MVD was 48 vessels/mm2, the range was 0–125 vessels/mm2. Using a cut-off value of the median MVD in the Kaplan-Meier analysis, the median survival was 22.2 months in the group with the higher MVD and was not reached in the group with the lower MVD (P<0.01). In a multivariate Cox regression analysis, using previously identified prognostic factors β2-microglobulin, C-reactive protein (CRP), and age, MVD remained significant as a prognostic factor (P<0.03).
ACCESSION #
15684635

 

Related Articles

  • Levels of angiogenic factors in patients with multiple myeloma correlate with treatment response. Pour, Ludek; Svachova, Hana; Adam, Zdenek; Almasi, Martina; Buresova, Lucie; Buchler, Tomas; Kovarova, Lucie; Nemec, Pavel; Penka, Miroslav; Vorlicek, Jiri; Hajek, Roman // Annals of Hematology;Apr2010, Vol. 89 Issue 4, p385 

    Angiogenesis plays a significant role in the pathogenesis of multiple myeloma (MM). We have measured concentrations of angiogenesis activators, including vascular endothelial growth factor (VEGF), basic fibroblast growth factor, and hepatocyte growth factor (HGF), and inhibitors, including...

  • Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial. Bhutani, M; Turkbey, B; Tan, E; Kemp, T J; Pinto, L A; Berg, A R; Korde, N; Minter, A R; Weiss, B M; Mena, E; Lindenberg, L; Aras, O; Purdue, M P; Hofmann, J N; Steinberg, S M; Calvo, K R; Choyke, P L; Maric, I; Kurdziel, K; Landgren, O // Leukemia (08876924);Feb2014, Vol. 28 Issue 2, p413 

    A letter to the editor is presented regarding prospective clinical trial on the increased angiogenesis of the bone marrow (BM) in multiple myeloma (MM) and its precursor disease.

  • CD45 expression by bone marrow plasma cells in multiple myeloma: clinical and biological correlations. Kumar, S.; Rajkumar, S. V.; Kimlinger, T.; Greipp, P. R.; Witzig, T. E. // Leukemia (08876924);Aug2005, Vol. 19 Issue 8, p1466 

    Multiple myeloma (MM) is characterized by accumulation of clonal plasma cells (PCs). CD45, a key regulator of antigen-mediated signaling and activation in lymphocytes, is present in early stages of PCs development. We studied CD45 expression on MM PCs by flow cytometry, correlating it to...

  • Value of F-fluorodeoxyglucose uptake in positron emission tomography/computed tomography in predicting survival in multiple myeloma. Haznedar, Rauf; Akı, Sahika; Akdemir, Özgür; Özkurt, Zübeyde; Çeneli, Özcan; Yağcı, Münci; Sucak, Gulsan; Ünlü, Mustafa // European Journal of Nuclear Medicine & Molecular Imaging;Jun2011, Vol. 38 Issue 6, p1046 

    Purpose: We assessed the role of the maximum standardized uptake value (SUV) of bone marrow and the extramedullary lesion with the highest SUV in positron emission tomography/computed tomography (PET/CT) of newly diagnosed multiple myeloma (MM) patients in predicting overall survival (OS)....

  • F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma. Ak, İlknur; Gulbas, Zafer; Ak, Ilknur // Annals of Hematology;Jan2011, Vol. 90 Issue 1, p81 

    The percentage of myeloma cells in bone marrow is subsequently an important index of disease in patients with multiple myeloma (MM). Bone marrow myeloma cells can be detected by strong CD38/CD138 positivity and light scatter characteristics using flow cytometry. The aim of the study was to...

  • Pulmonary and nodal multiple myeloma mimicking lymphoma. P O'Sullivan; N L Müller // British Journal of Radiology;Jul2006, Vol. 79 Issue 943, pe25 

    Multiple myeloma is a haematological malignancy characterized by the occurrence of plasma cell tumours within the bone marrow. In advanced multiple myeloma, metastatic deposits outside the bone marrow (extramedullary) are rare. Reported extramedullary sites include the upper respiratory tract...

  • Crystalline Inclusions in Plasma Cell Myeloma. Patriarca, Carlo; Giunta, Paolo; Di Pasquale, Marcello; Comandë, Mario // International Journal of Surgical Pathology;Jul2007, Vol. 15 Issue 3, p301 

    The article discusses the possibility of crystalline inclusions in plasma cell myeloma. According to bone marrow biopsy exhibits, the infiltration of cells is filled with pink diamond-shaped and rectangular inclusions. Plasma cellular nature of the cell was confirmed by CD138 immunoreactivity...

  • Serum albumin level is a significant prognostic factor reflecting disease severity in symptomatic multiple myeloma. Jeong Eun Kim; Changhoon Yoo; Dae Ho Lee; Sang-We Kim; Jung-Shin Lee; Cheolwon Suh // Annals of Hematology;Apr2010, Vol. 89 Issue 4, p391 

    Serum albumin level, in association with serum interleukin-6 level, is a significant prognostic factor in multiple myeloma patients. The aim of this study was to determine any clinical factors associated with decreased serum albumin level. We retrospectively reviewed the records of 373 patients...

  • Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor. Broek, I. Vande; Asosingh, K.; Allegaert, V.; Leleu, X.; Facon, T.; Vanderkerken, K.; Van Camp, B.; van Riet, I. // Leukemia (08876924);May2004, Vol. 18 Issue 5, p976 

    The migration of multiple myeloma (MM) cells from the circulation into the bone marrow (BM) implicates that they must have the capacity to cross the BM endothelium including the subendothelial basement membrane. In this study, human CD138+ MM cells were immunomagnetically isolated from BM...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics